Pharamocokinetics study of recombinant thrombomodulin in pediatric patients with hematological disease

Trial Profile

Pharamocokinetics study of recombinant thrombomodulin in pediatric patients with hematological disease

Completed
Phase of Trial: Phase II

Latest Information Update: 12 Mar 2016

At a glance

  • Drugs Thrombomodulin alfa (Primary)
  • Indications Disseminated intravascular coagulation; Embolism and thrombosis
  • Focus Pharmacokinetics
  • Most Recent Events

    • 12 Mar 2016 Population pharmacokinetic analysis (n=8) presented at the 117th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
    • 12 Mar 2016 Results (n=8) presented at the 117th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics
    • 20 Nov 2015 Status changed from not yet recruiting to completed, according to University Hospital Medical Information Network - Japan record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top